Anteris Technologies Global Corp. (AVR) vs Faeth Therapeutics, Inc. (FTH)

A side-by-side comparison of Anteris Technologies Global Corp. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVR vs FTH

growth of $100 · dividends reinvested · last 2y
AVR +34.8% (+16.1%/yr)FTH +215.1% (+77.5%/yr)FTH compounded faster over this window
100200300400Start $10020252026$135$315
AVR FTH

AVR vs FTH: by the numbers

  • •AVR is the larger company ($734M vs $699M market cap).
  • •Both run net losses; FTH's is the smaller (0.00% vs -4619.67% net margin).

Metrics side by side

Valuation

MetricAVRFTH
P/S ratio327.43N/A
P/B ratio2.924.04

Profitability

MetricAVRFTH
Gross margin-16.57%0.00%
Operating margin-4908.21%0.00%
Net margin-4619.67%0.00%
ROE-41.20%-113.05%
ROIC-41.63%-110.62%

Growth (annualized)

MetricAVRFTH
Revenue CAGR (5Y)-18.92%N/A
Total return CAGR (5Y)N/A-31.75%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.